NAPOLI-3: A randomized, open-label phase 3 study of liposomal irinotecan+5-fluorouracil/leucovorin plus oxaliplatin (NALIRIFOX) versus nab-paclitaxel plus gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).

被引：0

作者：

Wainberg, Zev A.

Melisi, Davide

Macarulla, Teresa

Pazo-Cid, Roberto

Chandana, Sreenivasa R.

De La Fouchardiere, Christelle

Dean, Andrew Peter

Kiss, Igor

Lee, Woojin

Goetze, Thorsten Oliver

Van Cutsem, Eric

Paulson, Andrew Scott

Bekaii-Saab, Tanios S.

Pant, Shubham

Hubner, Richard

Xiao, Zhimin

Chen, Huanyu

Benzaghou, Fawzi

O'Reilly, Eileen Mary

机构：

[1] UCLA Med Ctr Santa Monica, Santa Monica, CA USA

[2] Azienda Osped Univ Integrata, Invest Canc Therapeut Clin Unit, Verona, Italy

[3] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain

[4] Hosp Univ Miguel Servet, Zaragoza, Spain

[5] Western Michigan Canc Ctr, Kalamazoo, MI USA

[6] Lyon I Univ, Ctr Leon Berard, Dept Med Oncol, Lyon, France

[7] St John God Hosp, Subiaco, WA, Australia

[8] Masarykuv Onkol Usta, Brno, Czech Republic

[9] Natl Canc Ctr, Ctr Breast Canc, Goyang, South Korea

[10] Krankenhaus NW Frankfurt, Inst Klin Krebsforsch IKF, Frankfurt, Germany

[11] Krankenhaus NW Frankfurt, Univ Canc Ctr, Frankfurt, Germany

[12] Univ Leuven, Leuven, Belgium

[13] Texas Oncol PA, Dallas, TX USA

[14] Mayo Clin Canc Ctr Scottsdale, Phoenix, AZ USA

[15] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[16] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England

[17] Ipsen Corp, Cambridge, MA USA

[18] IPSEN, Paris, France

[19] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA661

引用

页码：LBA661 / LBA661

页数：1